Canon Will Use Caliper's LabChip Tech to Develop Screening, Dx Products | GenomeWeb
NEW YORK (GenomeWeb News) — Canon US Life Sciences, a division of Canon USA, today said it is using Caliper Life Sciences’ LabChip microfluidics technology and thermal analysis to develop genetic screening and diagnostic products.
 
Canon said it will use the technologies to shorten processing time and reduce the cost of gene diagnosis, and to enable rapid previews of genes for clinical use.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.